Martingale Asset Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-99,737
Closed -$5.49M 904
2016
Q1
$5.49M Sell
99,737
-193,875
-66% -$10.6M 0.11% 228
2015
Q4
$18.1M Buy
293,612
+64,001
+28% +$4.04M 0.4% 72
2015
Q3
$14.5M Buy
229,611
+169,227
+280% +$12.1M 0.35% 88
2015
Q2
$4.41M Buy
60,384
+38,452
+175% +$2.78M 0.1% 232
2015
Q1
$1.44M Buy
+21,932
New +$1.46M 0.03% 405
2014
Q2
Sell
-10,905
Closed -$714K 949
2014
Q1
$714K Sell
10,905
-116,537
-91% -$7.59M 0.02% 595
2013
Q4
$7.9M Sell
127,442
-57,529
-31% -$3.33M 0.27% 96
2013
Q3
$9.92M Sell
184,971
-38,790
-17% -$2M 0.35% 64
2013
Q2
$10.2M Buy
+223,761
New +$9.7M 0.38% 52

Other funds holding STJ

Martingale Asset Management's STJ Position: Q2 2016 in Review

Martingale Asset Management sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 99,737 shares — an estimated $5.49M sold.

Martingale Asset Management first reported a position in STJ in Q2 2013 and held it in 9 quarters. The position peaked at $18.1M in Q4 2015. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

  • Martingale Asset Management reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
  • Martingale Asset Management sold 99,737 St Jude Medical shares in Q2 2016, an estimated $5.49M.
  • Martingale Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 9 quarters.
  • Martingale Asset Management's St Jude Medical position peaked at $18.1M in Q4 2015.
  • 615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Martingale Asset Management's 13F filing for Q2 2016, filed 11 Aug 2016.